ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,552,830 | -2.0% | 614,618 | -6.6% | 4.51% | +6.3% |
| Q2 2023 | $58,713,380 | -23.3% | 657,853 | -7.9% | 4.24% | -26.5% |
| Q1 2023 | $76,551,435 | -12.3% | 713,966 | -0.1% | 5.77% | -17.6% |
| Q4 2022 | $87,257,122 | -11.0% | 714,461 | -24.8% | 7.01% | +1.0% |
| Q3 2022 | $98,088,000 | -4.9% | 949,915 | -14.4% | 6.94% | +21.0% |
| Q2 2022 | $103,155,000 | -27.0% | 1,109,670 | -7.8% | 5.74% | +18.8% |
| Q1 2022 | $141,300,000 | -19.9% | 1,203,990 | -8.2% | 4.83% | +3.1% |
| Q4 2021 | $176,492,000 | -19.7% | 1,311,915 | -4.9% | 4.68% | -7.1% |
| Q3 2021 | $219,781,000 | +48.8% | 1,378,887 | +22.8% | 5.04% | +53.4% |
| Q2 2021 | $147,687,000 | +18.0% | 1,122,671 | +15.6% | 3.29% | -0.4% |
| Q1 2021 | $125,156,000 | +7.0% | 971,105 | +38.4% | 3.30% | -8.2% |
| Q4 2020 | $117,012,000 | +38.6% | 701,594 | +28.3% | 3.59% | -8.0% |
| Q3 2020 | $84,416,000 | +26.2% | 547,022 | +21.0% | 3.90% | -5.8% |
| Q2 2020 | $66,866,000 | +69.0% | 452,104 | +28.7% | 4.14% | -7.4% |
| Q1 2020 | $39,570,000 | +13.3% | 351,388 | +40.0% | 4.47% | -0.3% |
| Q4 2019 | $34,915,000 | +171.1% | 250,972 | +87.7% | 4.48% | +31.1% |
| Q3 2019 | $12,877,000 | +1.0% | 133,689 | +20.7% | 3.42% | -15.2% |
| Q2 2019 | $12,752,000 | +20.3% | 110,740 | +23.0% | 4.03% | -1.8% |
| Q1 2019 | $10,601,000 | +292.9% | 90,065 | +109.1% | 4.10% | +102.9% |
| Q4 2018 | $2,698,000 | – | 43,065 | – | 2.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |